Patents by Inventor Van Tsai

Van Tsai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND COMPOSITIONS FOR GENE THERAPY
    Publication number: 20080107629
    Abstract: The present invention relates to improved methods for gene therapy, particularly gene therapy using PEGylated adenovirus. In particular the invention provides methods and compositions for mitigating the adverse effects associated with systemic administration of recombinant adenovirus for gene therapy.
    Type: Application
    Filed: September 28, 2007
    Publication date: May 8, 2008
    Inventors: Drake LaFace, Van Tsai
  • Methods for ex vivo therapy using peptide-loaded antigen presenting cells for the activation of CTL
    Patent number: 5846827
    Abstract: Methods for activating cytotoxic T lymphocytes (CTL) in vitro are presented in conjunction with methods for using the activated CTL for therapy in vivo. Additionally, a method for killing specific CTL in vivo is presented using antigen presenting cells which were modified in vitro.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: December 8, 1998
    Assignee: Cytel Corporation
    Inventors: Esteban Celis, Ralph Kubo, Horacio Serra, Van Tsai, Peggy Wentworth